|
|
Volumn 7, Issue 4, 2005, Pages 169-172
|
|
Orphan drugs and orphan tests in the USA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ORPHAN DRUG;
COST BENEFIT ANALYSIS;
DNA DETERMINATION;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG RESEARCH;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
GENETIC DISORDER;
HUMAN;
LABORATORY TEST;
LAW;
NOTE;
PRIORITY JOURNAL;
QUALITY CONTROL;
RARE DISEASE;
UNITED STATES;
DRUG INDUSTRY;
HUMANS;
LEGISLATION, DRUG;
ORPHAN DRUG PRODUCTION;
RARE DISEASES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 14044252769
PISSN: 14222795
EISSN: None
Source Type: Journal
DOI: 10.1159/000082255 Document Type: Note |
|
Times cited : (3)
|
|
References (6)
|
